| 12397006 |
Fospropofol formulations |
Steven L. Krill |
2025-08-26 |
|
| 12377110 |
Fospropofol methods and compositions |
Steven L. Krill, Michael A. Rogawski, Edward Brendan Magrab, Allen H. Heller |
2025-08-05 |
|
| 12370199 |
Fulvestrant formulations and methods of their use |
Steven L. Krill, Rama Abu Shmeis |
2025-07-29 |
|
| 12268742 |
Nanotherapeutic systems and methods using particle-driven photodynamic therapy (PDT) |
Michelle S. Bradbury, Ulrich Wiesner, Snehal G. Patel, Brian Madajewski, Daniella Karassawa Zanoni |
2025-04-08 |
|
| 12186427 |
Fulvestrant formulations and methods of their use |
Steven L. Krill, Rama Abu Shmeis, Adrian HEPNER, Charles Wescott, Tara Jaskowski +1 more |
2025-01-07 |
|
| 12115164 |
Pemetrexed formulations |
Steven L. Krill |
2024-10-15 |
|
| 11957760 |
Folate receptor targeted nanoparticle drug conjugates and uses thereof |
Kai Ma, Aranapakam Mudumbai Venkatesan, Fei Wu, Melik Z. Turker, Thomas C. Gardinier +3 more |
2024-04-16 |
|
| 11793813 |
Pemetrexed formulations |
Steven L. Krill |
2023-10-24 |
$2,395,000 |
| 11744897 |
Folate receptor targeted nanoparticle drug conjugates and uses thereof |
Kai Ma, Aranapakam Mudumbai Venkatesan, Fei Wu, Melik Z. Turker, Thomas C. Gardinier +3 more |
2023-09-05 |
|
| 11628178 |
Fospropofol methods and compositions |
Steven L. Krill, Michael A. Rogawski, Edward Brendan Magrab, Allen H. Heller |
2023-04-18 |
|
| 11590077 |
Fulvestrant formulations and methods of their use |
Steven L. Krill, Rama Abu Shmeis, Adrian HEPNER, Charles Wescott, Tara Jaskowski +1 more |
2023-02-28 |
$4,058,000 |
| 11559591 |
Ultrasmall nanoparticles labeled with Zirconium-89 and methods thereof |
Michelle S. Bradbury, Ulrich Wiesner, Kai Ma |
2023-01-24 |
|
| 11478490 |
Fospropofol formulations |
Steven L. Krill |
2022-10-25 |
|
| 11439653 |
Fospropofol formulations |
Steven L. Krill |
2022-09-13 |
|
| 11207334 |
Fospropofol formulations |
Steven L. Krill |
2021-12-28 |
|
| 10548989 |
Nanoparticle immunoconjugates |
Michelle S. Bradbury, Thomas P. Quinn, Barney Yoo, Jason S. Lewis, Ulrich Wiesner +1 more |
2020-02-04 |
|
| 10233249 |
Antibodies and methods for treating estrogen receptor-associated diseases |
Xueming Qian, Kun Meng, Xiao Shang, Jing Wang, Lu Li +1 more |
2019-03-19 |
|
| 9034831 |
Pharmaceutical composition for a hepatitis C viral protease inhibitor |
Robert J. Schwabe |
2015-05-19 |
|
| 8460704 |
Extended release formulation of nevirapine |
Michael L. Cappola, Svetlana Sienkiewicz, Glenn Charles Snow |
2013-06-11 |
|
| 8389730 |
Compositions and methods for the treatment of disease associated with TRP-P8 expression |
Sateesh Natarajan, Ofir Moreno, Thomas Graddis, David F. Duncan, Reiner Laus |
2013-03-05 |
$15,776,000 |
| 8362264 |
Compositions and methods for the treatment of disease associated with Trp-p8 expression |
Sateesh Natarajan, Ofir Moreno, Thomas Graddis, David F. Duncan, Reiner Laus |
2013-01-29 |
$8,452,000 |
| 7605135 |
Baicalin as a treatment for SARS infection |
Kwok Yung Yuen, Kwok Hung Chan, Yi Tsun Richard Kao, Yi Guan, Leo Lit Man Poon +1 more |
2009-10-20 |
|
| 7374779 |
Pharmaceutical formulations and systems for improved absorption and multistage release of active agents |
Srinivasan Venkateshwaran, Steven L. Krill, Mahesh V. Patel |
2008-05-20 |
|
| 7323439 |
Methods and compositions for modulating angiogenesis |
Gerald R. Crabtree, Isabella A. Graef |
2008-01-29 |
|
| 6982281 |
Pharmaceutical compositions and dosage forms for administration of hydrophobic drugs |
Mahesh V. Patel |
2006-01-03 |
|
